In this paper, we describe an approach to measuring enzyme activity based on the reconfiguration of complex emulsions. Changes in the morphology of these complex emulsions, driven by enzyme-responsive surfactants, modulate the transmission of light through a sample. Through this method we demonstrate how simple photodetector measurements may be used to monitor enzyme kinetics. This approach is validated by quantitative measurements of enzyme activity for three different classes of enzymes (amylase, lipase, and sulfatase), relying on two distinct mechanisms for coupling droplet morphology to enzyme activity (host-guest interactions with uncaging and molecular cleavage).ioassays are used extensively in healthcare for the identification and quantification of biochemical markers, such as enzymes, which have long been known to be important diagnostic indicators for monitoring many diseases and health states. Tests indicating abnormal enzyme activity, in combination with physical examination, are used to diagnose many illnesses, such as pancreatitis (lipase and amylase) (1), myocardial infarction (creatine kinase) (2), and liver disease (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase) (3). Rather than quantify the concentration of these enzymes directly, clinicians usually monitor the production or consumption of an enzyme's substrate. Conventionally, clinical samples are tested by professional laboratories with specialized commercial equipment, and these assays often rely on a colorimetric or fluorogenic signal generated by enzyme action. Historically, reagent and equipment requirements for these assays have limited their use to professional laboratories in developed nations. The creation of point-of-care diagnostics which will enable rapid, lowcost, and personalized healthcare options offers the ability to improve the well-being of people, especially in developing countries (4,5). Such recent advances include development of portable quantum dot microspectrometer technology (6), paper-based bioassays (7), handheld portable devices for virus particle sizing using nanolenses (8), and smartphone-powered multiplex ELISAs (9). The emergence of smartphone-driven personal health monitoring (9-11) in particular creates a market for scalable, easily executed, inexpensive assays that harness built-in smartphone components (camera, light sensor, magnetometer, etc.) and automate interpretation. The continued development of conceptually novel approaches to bioassays, especially for enzymes, will be critical for the ongoing advancement of point-of-care technology and low-cost health monitoring.Stimuli-responsive "smart" materials have the ability to enable new diagnostic devices that expand the suite of sensitivities and readout mechanisms for point-of-care platforms (12). Recently, we described a facile approach to the fabrication of reconfigurable complex droplets (13) that, because of their exquisitely sensitive morphological response to targeted chemical stimuli, have significant promise as an easil...